Effects of Quercetin Treatment on Vascular Function in Deoxycorticosterone Acetate-Salt Hypertensive Rats. Comparative Study with Verapamil

Abstract

This study analysed and compared the effects of chronic oral treatment with quercetin or verapamil on systolic blood pressure and vascular function in deoxycorticosterone acetate (DOCA)-salt hypertensive rats. Quercetin and verapamil inhibited the development of DOCA-salt-induced hypertension in a similar manner. DOCA-salt-hypertensive rats showed potassium depletion and oxidative stress, prevented only by concomitant quercetin administration. Quercetin and verapamil treatments reduced the endothelium-independent hyper-reactivity to KCl observed in the aorta of DOCA-salt-hypertensive rats, but only quercetin increased the contractile responses to angiotensin II, improved endothelial dysfunction and restored basal aortic Cu/Zn SOD expression, altered in DOCA-salt-treated rats. In conclusion, quercetin and verapamil show similar antihypertensive effects in mineralocorticoid hypertension, but quercetin was superior to verapamil in improving endothelial-dependent aortic dilatation, suggesting a better vascular protection in this volume expansion hypertension model.

Quercetin - verapamil - mineralocorticoid hypertension - antioxidant - vascular reactivity - endothelial dysfunction

References

• 1 Middleton E, Kandaswami C, Theoharides T C. The effects of plant flavonoids on mammalian cells: Implications for inflammation, heart disease, and cancer.  Pharmacol Rev. 2000;  52 673-751
• 2 Hertog M GL, Feskens E JM, Hollman P CH, Katan M B, Kromhout D. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study.  Lancet. 1993;  342 1007-11
• 3 Yochum L, Kushi L H, Meyer K, Folsom A R. Dietary flavonoid intake and risk of cardiovascular disease in postmenopausal women.  Am J Epidemiol. 1999;  149 943-9
• 4 Gryglewski R J, Korbut R, Robak J, Swies J. On the mechanism of antithrombotic action of flavonoids.  Biochem Pharmacol. 1987;  36 317-22
• 5 Duarte J, Pérez-Vizcaíno F, Zarzuelo A, Jiménez J, Tamargo J. Vasodilator effects of quercetin in isolated rat vascular smooth muscle.  Eur J Pharmacol. 1993;  239 1-7
• 6 Duarte J, Pérez-Palencia R, Vargas F, Ocete M A, Pérez-Vizcaíno F, Zarzuelo A. et al . Antihypertensive effects of the flavonoid quercetin in spontaneously hypertensive rats.  Br J Pharmacol. 2001;  133 117-24
• 7 Duarte J, Galisteo M, Ocete M A, Pérez-Vizcaíno F, Zarzuelo A, Tamargo J. Effects of chronic quercetin treatment on hepatic oxidative status of spontaneously hypertensive rats.  Mol Cell Biochem. 2001;  221 155-60
• 8 Duarte J, Jiménez R, O’Valle F, Galisteo M, Pérez-Palencia R, Vargas F. et al . Protective effects of the flavonoid quercetin in chronic nitric oxide deficient rats.  J Hypertens. 2002;  20 1843-54
• 9 Hollenberg N K, Coletti C, Passan D. Hypertension, volume and vasoconstriction: studies on the renal blood supply in SHR, WKY and DOCA-salt rat models.  Hypertens Res. 1992;  15 3-11
• 10 Somers M J, Mavromatis K, Galis Z S, Harrison D G. Vascular superoxide production and vasomotor function in hypertension induced by deoxycorticosterone acetate-salt.  Circulation. 2000;  101 1722-8
• 11 Beswick R A, Zhang H, Marable D, Catravas J D, Hill W D, Webb R C. Long-term antioxidant administration attenuates mineralocorticoid hypertension and renal inflammatory response.  Hypertension. 2001;  37 781-6
• 12 Frochlich E, Apstein C, Chobanian A, Devereux R, Dustan H, Dzau V. et al . The heart in hypertension.  N Engl J Med. 1993;  327 998-1008
• 13 Wangensteen R, O’Valle F, Del Moral R G, Vargas F, Osuna A. Chronic α1-adrenergic blockade improves hypertension and renal injury in L-NAME and low-renin L-NAME-DOCA hypertensive rats.  Med Sci Monit. 2002;  8 378-84
• 14 Longhurst P A, Rice P J, Taylor D A, Fleming W W. Sensitivity of caudal arteries and the mesenteric vascular bed to norepinephrine in DOCA-salt hypertension.  Hypertension. 1988;  12 133-42
• 15 Counture R, Regoli D. Vascular reactivity to angiotensin and noradrenaline in rats maintained on sodium free or made hypertensive with deoxycorticosterone acetate and salt (DOCA/salt).  Clin Exp Hypertens. 1980;  2 25-43
• 16 White R M, Rivera C O, Davison C B. Differential contribution of endothelial function to vascular reactivity in conduit and resistance arteries from deoxycorticosterone-salt hypertensive rats.  Hypertension. 1996;  27 1245-53
• 17 Storm D S, Webb R C. α-adrenergic receptors and ⁴⁵Ca²⁺ efflux in arteries from deoxycorticosterone acetate hypertensive rats.  Hypertension. 1992;  19 734-8
• 18 Molero M M, Giulumian A D, Reddy V B, Ludwig L M, Pollock J S, Pollock D M,. et al . Decreased endothelin binding and [Ca²⁺]_i signaling in microvessels of DOCA-salt hypertensive rats.  J Hypertens. 2002;  20 1799-805
• 19 Linas S L, Marzec-Calvert R, Ullian M E. K depletion alters angiotensin II receptor expression in vascular smooth muscle cells.  Am J Physiol. 1990;  258 C849-54
• 20 Álvarez G, Osuna A, Wangensteen R, Vargas F. Interaction between nitric oxide and mineralocorticoids in the long-term control of blood pressure.  Hypertension. 2000;  35 752-7
• 21 Mian K B, Martin W. Differential sensitivity of basal and acetylcholine-stimulated activity of nitric oxide to destruction by superoxide anion in rat aorta.  Br J Pharmacol. 1995;  115 993-1000